A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter].

Onco Targets Ther

Center for Biomedical Research, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong Science Center, Cibinong, West Java, Indonesia.

Published: November 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700466	PMC
http://dx.doi.org/10.2147/OTT.S396245	DOI Listing

Publication Analysis

Top Keywords

response article

article anlotinib

anlotinib hydrochloride

hydrochloride pd-1

pd-1 blockade

blockade salvage

salvage second-line

second-line treatment

treatment patients

patients progress

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

A Response to Article Anlotinib Hydrochloride and PD-1 Blockade as a Salvage Second-Line Treatment in Patients with Progress of Local Advanced Non-Small Cell Lung Cancer in Half a Year after Standard Treatment [Letter].

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?